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AbstrACt
Objective This study explores the factors associated 
with health service use for individuals with cardiovascular 
disease (CVD) and comorbidity in the Ireland.
Design Population-based cross-sectional survey.
setting Nationally representative health and health 
service use survey from the 2010 Quarterly National 
Household Survey was analysed.
Primary outcome measures Four outcome variables 
were examined: no CVD, CVD only, CVD with CVD-related 
comorbidities and CVD with non-CVD-related comorbidity.
results Of the 791 individuals reporting doctor-
diagnosed CVD, 77% had a second morbidity. Using type 
of healthcare coverage as a proxy for socioeconomic 
status, both CVD-related and non CVD-related comorbidity 
increases the use of health service usage substantially 
for individuals with CVD, particularly general practitioner 
services (8.47, CI 4.49 to 15.96 and 5.20, CI 2.10 to 12.84) 
and inpatient public hospital care (3.64, CI 2.93 to 4.51 
and 3.00, CI 2.11 to 4.26).
Conclusion This study indicated that even when 
demographic and socioeconomic factors are controlled for, 
comorbidity significantly increases the risk of accessing 
health services for individuals with CVD.
IntrODuCtIOn 
The WHO has projected that cardiovas-
cular disease (CVD) alone will account for a 
quarter of global deaths by 2030.1 While WHO 
mortality estimates indicate that deaths asso-
ciated with CVD in Ireland have decreased in 
the last decade2 and that disability adjusted 
life-years attributable to CVD are lower in 
Ireland than the European average,3 CVD 
burden comes from deaths and from those 
living with the disease.4 At the same time, the 
number of patients with CVD presenting with 
multiple coexistent diseases, or comorbidity 
is expected to increase. Comorbidity has 
important implications for healthcare use and 
related costs and represents a key future chal-
lenge for healthcare systems.5 6 To ensure the 
optimum organisation and delivery of health-
care services to treat comorbidity, an under-
standing (a) of the range of services used by 
individuals with comorbidity5 6 and (b) the 
socioeconomic profile of these service users 
is required.7–10 A frequently employed tool 
to understand health service use is Anders-
en’s Behavioural Model of Health Service 
Use (BMHSU),11 which assumes that indi-
viduals’ use of services is a function of their 
predisposition to use services (predisposing 
factors), factors that support or impede use 
(enabling factors), as well as their need for 
healthcare (needs-related factors).12–14 After 
presenting the prevalence figures of comor-
bidity for individuals with CVD, this paper 
uses Andersen’s BMHSU to examine the 
impact of comorbidity in individuals with 
CVD on the use of general practitioner (GP), 
pharmacy and both public and private inpa-
tient hospital care.
DAtA
Collected by the Central Statistics Office 
(CSO), the Quarterly National Household 
Survey (QNHS) is a representative microlevel 
data set for the whole of Ireland.15 While the 
main purpose of the QNHS is the production 
of quarterly labour force estimates, in 2010 a 
special module on health and health service 
utilisation was collected. This module was 
commissioned by a specially created health 
liaison group, which comprised experts in 
several fields of medical research and officials 
in the Department of Health. To assess health-
care use, the QNHS health module collected 
strengths and limitations of this study
 ► This study uses a representative population sur-
vey to examine health service use for people with 
comorbidities.
 ► The use of a healthcare coverage variable allows a 
socioeconomic analysis of health service usage for 
individuals with the same comorbidity profile.
 ► A limitation is that the dependent variables are 
based on self-reported, doctor diagnosed rather 
than clinical data.
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detailed information for different health services in the 
preceding 12 months including the number of times an 
individual used a GP service, pharmacy and inpatient 
hospital service (divided into public and private care). 
The number of nights in hospital (again, divided by 
public and private use) for inpatients is also collected. 
Containing data on 15 673 individuals,15 the health 
module collected in Quarter 3, 2010 forms the basis of 
Anderson’s BMHSU framework presented in this paper.
The individual characteristics used in this study, 
grouped by predisposing, enabling and need factors are 
presented in figure 1. In line with previous research on 
comorbidity,11–13 the predisposing factors used in this 
analysis include age and sex. With regard to enabling 
factors, this paper focuses on the economic means by 
which individuals may access healthcare in Ireland. 
Healthcare provision in Ireland is a mix of public and 
private provision,16 with eligibility for free healthcare 
means tested on an annual basis. In 2010 (the year of 
focus for this paper), individuals under a specific income 
level; all individuals over 70 years old and individuals 
with a number of long-term illnesses qualified for what 
is a medical card, which entitles them to free primary 
and acute health services in public hospitals. Then, rest 
of the population either paid the full economic cost for 
health services (GP, dentists, opticians and pharmacists) 
or a heavily subsided fee (hospital services) at the point 
of contact.16 Despite the heavily subsided fee associated 
with hospital care, and the majority of private insurance 
plans only covering hospital stays, half the Irish popula-
tion paid for private health insurance during this time 
period.15 Given that all Irish citizens can avail of either 
free (medical card holders) or heavily subsidised inpa-
tient care (the rest of the population), previous health 
research in Ireland has used coverage type as a proxy 
for socioeconomic status (SES) from the medical card 
(lowest), to the non-covered, to the privately insured 
(highest).17 18 This distinction has led researchers to 
use medical card ownership (lowest SES), non-covered 
(neither medical card or privately covered), privately 
insured (highest SES) as a proxy for income-based SES 
in the Ireland.17 18 Within this context, private health 
insurance, along with education level were included as 
the enabling factors within this analysis.
Regarding need factors, the QNHS Health and Health 
Service Use module contains four health conditions that 
taken together create a CVD variable: angina (chest pain 
on exertion due to inadequate blood flow to the heart 
muscle), stroke, myocardial infarction (heart attack) and 
heart failure. The QNHS data for 2010 contain 13 further 
morbidities that may be grouped as either CVD-related 
or non-CVD-related morbidities (table 1). In terms of the 
classification of the comorbidities as either CVD-related 
or CVD non-related, hypertension (40%) and choles-
terol (30%) are the two diseases with the highest inci-
dence of comorbidity with CVD (table 1). High levels of 
cholesterol and hypertension are well-documented risk 
factors for CVD and this is usually controlled with medi-
cation. These diagnoses are thus classified as CVD-related 
comorbidities. The other 11 morbidities (table 1) are 
grouped together as non-related CVD comorbidity. The 
next highest comorbid conditions are diabetes (11%) 
and osteoarthritis (11%). While diabetes often presents 
as comorbidity with CVD,12 as the health service provision 
associated with diabetes (metabolic) and CVD (vascular) 
are typically not integrated across and between different 
healthcare service,12 for the purpose of this health service 
focused paper, diabetes is classified as a non-related 
comorbidity.
Figure 1 Andersen’s behavioural model of health service 
use. CVD, cardiovascular disease; GP, general practitioner.
Table 1 Comorbidity of cardiovascular disease (CVD) with 
13 other morbidities in the Ireland
Comorbidity with 
CVD (angina, 
stroke, myocardial 
infarction or heart 
failure (%))
CVD-related or non-related 
morbidity
Asthma 6 Non-CVD-related morbidity
Bronchitis 6 Non-CVD-related morbidity
Hypertension 40 CVD-related morbidity
Cholesterol 30 CVD-related morbidity
Cancer 5 Non-CVD-related morbidity
Diabetes 11 Non-CVD-related morbidity
Rheumatoid arthritis 4 Non-CVD-related morbidity
Osteoarthritis 11 Non-CVD-related morbidity
Osteoporosis 3 Non-CVD-related morbidity
Depression/anxiety 7 Non-CVD-related morbidity
Epilepsy 1 Non-CVD-related morbidity
Urinary incontinence 4 Non-CVD-related morbidity
Other condition 10 Non-CVD-related morbidity
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MethODs
This paper categorised the incidence of CVD-based 
morbidity as three mutually exclusive categories:CVD 
only, CVD-related comorbidity and non-CVD-related 
comorbidity. For the purpose of comparison, a fourth 
category is included, respondents stating they were never 
diagnosed with CVD. Descriptive statistics on individual 
demographic (predisposing factors), socioeconomic 
(enabling factors) and healthcare use (needs-based 
factors) measures are listed for individuals without CVD, 
CVD only, CVD-related comorbidity and CVD non-related 
comorbidity. As each of the CVD categories were coded 
as binary yes/no dummy variables logistic models were 
employed, adjusting for age, gender and educational 
level. The effect sizes as results of the logistic regres-
sion models were expressed as ORs and 95% CI were 
calculated.
Patient and public involvement
This study is a secondary analysis of the QNHS for 
the Ireland provided by the CSO. Study design and 
development was not informed by patient input. We are 
not aware of the CSO plans for dissemination of results to 
study participants.
results
Examining the CVD dummy variables, 5% (791 individ-
uals) of survey respondents reported having been diag-
nosed with CVD by a doctor (table 2). Of the individuals 
who had been diagnosed with CVD, 22.5% of individuals 
(179) were diagnosed with only CVD, 57.8% had a CVD-re-
lated comorbidity (hypertension and or cholesterol) and 
38.6% had a non CVD-related comorbidity (one or more 
of the diagnosed categories outlined in table 1). These 
rates represent a 1%, 2.9% and 0.99% prevalence rate 
for CVD only, CVD-related comorbidity and non-CVD-re-
lated comorbidities across the Irish population (table 3).
Descriptive statistics
Table 3 presents descriptive statistics on individual 
demographic (predisposing factors) and socioeconomic 
(enabling factors) for the overall sample and for individ-
uals without CVD, CVD only, CVD-related comorbidity 
and CVD non-related comorbidity. Examining the break-
down of coverage for participants in the QNHS, 19% of 
the sample had no coverage (paid at point of contact), 
31% had a medical card (all public health services for 
free), 41% had private health insurance (covering private 
hospital care) and 8% had both a medical card and private 
health insurance. Individuals with CVD only were more 
likely to be male (66%); however, no gender differences 
were observed for individuals with CVD-related comorbid-
ities, more women (52%) reported to have non-CVD-re-
lated morbidities. This finding is similar to previous 
research that has found that in the general population, 
Table 2 Rate of doctor-diagnosed cardiovascular disease 
(CVD), CVD only, CVD-related morbidity and CVD non-
related morbidity across the Irish Population
% General 
population
% 
Population 
with CVD Count
CVD 5.05 791
CVD only 1.14 22.5 179
CVD+related morbidities 
(hypertension+cholesterol)
2.92 57.8 457
CVD+non-related morbidities (all 
others)
0.99 19.6 155
Table 3 Individual characteristics for individuals without cardiovascular disease (CVD), CVD only, CVD-related comorbidity 
and CVD non-related comorbidity
Variable Overall sample No CVD CVD only
CVD+related 
morbidities
CVD+non related 
morbidities
Male (%) 38 37 66 51 48
Age 18–24 (%) 5 99 Less than 1% 0 Less than 1%
Age 25–44 (%) 41 99 Less than 1% Less than 1% Less than 1%
Age 45–64 (%) 33 95 1 3 Less than 1%
Age 64+ (%) 21 84 3 9 3
Low education (%) 20 18 47 56 53
Medium education (%) 36 36 36 29 25
High education (%) 42 43 16 15 20
Education unspecified 2.2 2 1 Less than 1% 3
No coverage (%) 19 20 11 6 4
Medical card (%) 31 30 52 62 60
Private insurance (%) 41 42 20 13 12
Both medical card and private 
health insurance (%)
8 8 18 19 25
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there were more women than men with comorbidity.7 A 
clear age gradient is observed with younger individuals 
reporting the lowest rates of all morbidity categories, with 
the age category over 65 years old see a large increase in 
individuals reporting CVD-related (9%) and non-related 
(3%) comorbidities.
With regard to education level, individuals with high 
education had the lowest rates of all morbidity catego-
ries. Individuals with CVD-related comorbidities (81%) 
and non-CVD-related morbidities (85%) have higher 
rates of medical card eligibility compared with individ-
uals without CVD (38%) and individuals with CVD only 
(70%). In terms of healthcare coverage, individuals with 
private health insurance have the highest rates of no CVD, 
while individuals with medical cards report the highest 
rates for each morbidity category. Importantly, people 
without either a medical or private health insurance have 
the lowest rates of each morbidity. A cross-tabulation of 
coverage by age class indicates that this may be related 
to the age profile of individuals with the majority of the 
sample without either a medical card of private health 
insurance aged between 18 and 44 years old.
Table 4 presents the percentage of individuals with 
each of the four morbidity categories that accessed GP 
services, pharmacies and inpatient hospital services in 
both public and private hospitals. Table 4 also pres-
ents the percentage of individuals by morbidity, health 
service usage and type of healthcare coverage. Exam-
ining morbidity by health service accessed first, with the 
exception of having visited a pharmacy, the descriptive 
statistics show that there is a clear gradient between not 
being diagnosed with CVD and having CVD, CVD-re-
lated morbidities and CVD non-related comorbidities 
for each health service. Individuals with CVD, CVD-re-
lated, and CVD non-related morbidities report much 
higher GP and public inpatient hospital use. Using 
health coverage type as a proxy for SES, table 4 shows 
that individuals with a medical card and CVD, CVD-re-
lated and CVD non-related morbidities accessed GP, 
pharmacy and inpatient hospital care compared with all 
other coverage types. As expected, the individuals with 
private health insurance had the highest levels of private 
inpatient hospital care.
Table 4 Mean healthcare use measures for individuals without cardiovascular disease (CVD), CVD only, CVD-related 
comorbidity and CVD non-related comorbidity
Variable No CVD CVD only
CVD+related 
morbidities
CVD+non-related 
morbidities
General practitioner 77 93 98 97
Pharmacy 40 42 45 44
Inpatient public 9 27 32 32
Inpatient private 2 2 6 5
Doctor
No coverage 16 10 6 3
Medical card 33 53 62 60
Private health insurance 41 18 13 12
Both medical card and private health insurance 9 19 19 25
Pharmacy
No coverage 17 12 8 1
Medical card 32 49 64 68
Private health insurance 43 19 11 12
Both medical card and private health insurance 8 20 17 19
Inpatient public
No coverage 13 15 5 0
Medical card 37 38 61 61
Private health insurance 37 21 14 14
Both medical card and private health insurance 13 27 20 24
Inpatient private
No coverage 3 0 0 0
Medical card 6 0 3 0
Private health insurance 66 50 27 71
Both medical card and private health insurance 25 50 69 28
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logistic regression model
Incorporating predisposing, enabling and needs-based 
factors within a set of logistic models, table 5 indicates that 
individuals without CVD had a strong significant nega-
tive association with health service use in the previous 
12 months, GP visits (0.17, CI 0.12 to 0.26), pharmacy 
visits (0.73, CI 0.62 to 0.85), inpatient public hospital 
care (0.26, CI 0.41 to 0.87) and inpatient private hospital 
care (0.60, CI 0.41 to 0.87). Examining individuals with 
CVD only and CVD-based comorbidities, individuals with 
a CVD-related comorbidity had the largest increased risk 
for accessing GP services (8.47, CI 4.49 to 15.96) and 
pharmacy visits (1.38, CI 1.14 to 1.68). For both of these 
health services, having a comorbidity, both related and 
non-related had significantly higher OR compared with 
CVD only. For public inpatient services, having CVD, a 
CVD-related, and CVD non-related comorbidity were 
significantly associated with a 2.69 (CI 1.91 to 3.80), 3.64 
(CI 2.93 to 4.51) and 3.00 (CI 2.11 to 4.26) increased risk 
of having used these services in the previous 12 months. 
For private inpatient services, having CVD only has a 
negative, but insignificant association with service usage 
(0.65, 0.23 to 1.80). Individuals with CVD-related and 
CVD non-related comorbidities had a 2.09 (CI 1.36 to 
3.21) and 1.47 (CI 0.67 to 3.22) risk of having used these 
services in the previous 12 months.
DIsCussIOn
Data on the prevalence of key comorbidities and indi-
cators of healthcare use are useful in assessing current 
and future health service needs for individuals with CVD. 
This paper used Anderson’s BMHSU to examine the 
impact of CVD-based comorbidities on health service use 
in Ireland. Of the 791 individuals reporting doctor-diag-
nosed CVD, 77% had additional morbidities. High levels 
of cholesterol and hypertension are well-documented risk 
factors for CVD and this is usually controlled with medi-
cation and were therefore classed as CVD-related comor-
bidities. However, 11% and 11% of participants with CVD 
reported having being doctor diagnosed with diabetes 
and osteoarthritis, respectively. These results indicate that 
for individuals with CVD non-vascular comorbidities are 
important use drivers as vascular comorbidities. Similar 
to international research,7–10 the descriptive statistics 
presented show a clear socioeconomic gradient in terms 
of the prevalence of CVD and CVD plus comorbidities, 
with individuals with higher levels of education and 
private health insurance having lower levels of CVD and 
CVD-based comorbidities. In contrast, individuals with 
medical cards have higher levels of CVD and CVD-based 
comorbidities. The descriptive statistics on health service 
use indicated that individuals with CVD, CVD-related 
and CVD non-related morbidities report much higher 
GP and public inpatient hospital use. Examining use by 
health coverage type reconfirms the social gradient, indi-
viduals with a medical card and CVD, CVD-related and 
CVD non-related morbidities accessed GP, pharmacy and 
inpatient hospital care compared with all other coverage 
types. This indicates that in the Ireland, individuals with 
lower SES need to use more healthcare services compared 
with individuals with higher SES for the same doctor-diag-
nosed morbidities.
Controlling for demographic and socioeconomic 
factors via a logistic regression model, this analysis found 
that individuals with CVD non-related comorbidities had 
the largest significant association with GP visits and inpa-
tient treatment in both public and private hospitals. High 
GP usage indicates that individuals with CVD and comor-
bidities are being managed in the primary care sector; 
these results indicate a high clinical burden particularly 
for individuals with comorbidities on general practices. 
As a result of different factors, including ageing popu-
lations and advances in medical care and public health 
policy, the number of individuals presenting with more 
than one morbidity is expected to increase. Furthermore, 
the comorbidity of non-related CVD-based morbidities 
such as osteoarthritis indicate that primary care services 
are already dealing with patients with complex health 
demands and that adequate training and resources is 
required.
These results demonstrate that (1) health service usage 
increase significantly for individuals with comorbidities; 
(2) there is a clear socioeconomic gradient in the prev-
alence of CVD and CVD-based comorbidities in Ireland 
Table 5 Effect of comorbidity of individuals with cardiovascular disease (CVD) on healthcare use adjusted for age, gender, 
private hospital care and educational level (CI presented within brackets)
No CVD CVD CVD-related CVD non-related
General practitioner 0.17 2.69 8.47 5.20
(0.12 to 0.26) (1.48 to 4.90) (4.49 to 15.96) (2.10 to 12.84)
Pharmacy 0.73 1.28 1.38 1.24
(0.62 to 0.85) (0.94 to 1.74) (1.14 to 1.68) (0.90 to 1.72)
Inpatient public 0.26 2.69 3.64 3.00
(0.22 to 0.31) (1.91 to 3.80) (2.93 to 4.51) (2.11 to 4.26)
Inpatient private 0.60 0.65 2.09 1.47
(0.41 to 0.87) (0.23 to 1.80) (1.36 to 3.21) (0.67 to 3.22)
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and (3) individuals with lower SES status accessed more 
health services compared with individuals with higher 
SES. Although this paper did not conduct a formal 
health-economic analyses, our data suggest that lower 
SES as measured by education and health coverage type 
is likely to be associated with substantial variation in 
the costs of caring for people with CVD and a further 
morbidity. From a public health policy perspective, in 
addition to the beneficial effects of not having a range of 
morbidities on an individual’s quality of life, the preven-
tion of comorbidity can also curb the growing demands 
for healthcare, particularly among high-risk groups.7 8
study limitations
Limitations of the study need to be considered in inter-
preting the results. First, this study is based on a represen-
tative sample of the Irish population; however, the data 
are old and relates to 2009/2010. However, an analysis 
of this data is still important as while mortality due to 
CVD is decreasing, the burden of CVD and comorbidity 
is increasing, thus the data presented here are indicative 
of an upward trend in the healthcare service needs of the 
Irish population. Second, the dependent variables used 
in this study are based on self-reported doctor diagnosis 
rather than clinical records. It is important to note that 
there may be limitations on using a dependent variable 
that is self-reported, with regard to respondent memory 
and accuracy of diagnosis. However, this study believed 
that to understand the health service usage patterns and 
socioeconomic profile of individuals with a CVD-based 
comorbidity, a data set with representative sample of the 
Irish population was more appropriate than a clinical 
data set. Finally, as with as with all health analysis using 
survey data, survival bias needs to be noted.
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